Abstract P6-17-04: A phase II, open-label, multi-center study of ANG1005, a novel brain-penetrant taxane derivative, in breast cancer patients with recurrent CNS metastases
Year: 2016
Type: conference-abstract
Source: Cancer Research
Authors: S-C Tang, S Bates, S Kesari, AJ Brenner, CK Anders, A Garcia, NK Ibrahim, KHR Tkaczuk, P Kumthekar
Institutions: Northwestern University, University of North Carolina at Chapel Hill, University of Southern California, University of Maryland, Baltimore, National Institutes of Health, The University of Texas MD Anderson Cancer Center, The University of Texas at San Antonio Health Science Center, Augusta University, USC Norris Comprehensive Cancer Center, National Cancer Institute, Moores Cancer Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2405689775